Medical knowledge · Legal judgment · Human agency

Product Liability Litigation

Roundup Lawsuit

Lawsuits have been filed against Roundup manufacturers alleging that glyphosate causes cancer, that the company knew about cancer risks, and failed to provide adequate warnings.

Roundup Cancer Litigation

Roundup is a widely used herbicide containing glyphosate as its active ingredient. The International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" based on scientific evidence.

Thousands of lawsuits have been filed against the manufacturer alleging that Roundup causes non-Hodgkin's lymphoma and other cancers, and that the manufacturer failed to adequately warn consumers about cancer risks despite knowing about the risks.

Glyphosate and Cancer Risk

Scientific research has established that glyphosate exposure is associated with increased risk of non-Hodgkin's lymphoma and other malignancies. Agricultural workers, lawn care professionals, and home gardeners have all been exposed to Roundup through occupational or residential use.

The carcinogenic mechanism involves glyphosate's effects on the immune system and potential DNA damage. Chronic exposure to glyphosate creates cumulative cancer risk.

Known Risk and Suppressed Research

The manufacturer was aware of scientific evidence linking glyphosate to cancer but allegedly suppressed or downplayed this research. Internal documents obtained in litigation suggest the company knew about cancer risks but failed to disclose them to regulators and consumers.

Adequate warnings would have informed users about glyphosate cancer risks and recommended protective measures.

Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma is a serious blood cancer with significant morbidity and mortality. Lawsuits have documented cases of workers and consumers who developed NHL after years of Roundup exposure.

The latency period for NHL development can be years or decades after initial exposure, making the connection between exposure and cancer sometimes difficult to establish but not impossible with appropriate evidence.

Who May Qualify for a Claim

Individuals with occupational or residential Roundup exposure who have been diagnosed with non-Hodgkin's lymphoma or other cancer may have viable claims. Significant exposure duration increases the likelihood of a successful claim.

To evaluate your case, we need information about the type, duration, and intensity of Roundup exposure, the cancer diagnosis with documentation, and medical records relating to diagnosis and treatment.

Free Case Review

If you or a family member may have a Roundup cancer claim, MDLaw Firm can evaluate your claim based on your exposure history and medical records.

Start Your Review

No fees. No commitments. Confidential.

Key Facts

  • Product: Roundup (glyphosate)
  • Status: Settled and Ongoing
  • Injuries: Non-Hodgkin's lymphoma, other cancers
  • Evidence: Exposure history, cancer diagnosis, pathology reports, medical records

No attorney-client relationship is created by reading this page. Case results depend on specific facts. Consult an attorney for advice specific to your situation.